Skip to content

Efficacy of Acceptance and Commitment Therapy for the Management of Quality of Life in Patients Post Myocardial Infarction

Efficacy of Acceptance and Commitment Therapy for the Management of Quality of Life in Patients Post Myocardial Infarction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06548282
Enrollment
60
Registered
2024-08-12
Start date
2024-06-21
Completion date
2024-09-21
Last updated
2025-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Adherence, Psychological Distress, Quality of Life, Type D Personality

Brief summary

The present study aims to investigate the efficacy of acceptance and commitment therapy for the management of quality of life in patients post-myocardial infarction

Detailed description

The current quantitative study is carried out in two steps. A cross-sectional survey assesses quality of life and associated factors during the first step. A randomized controlled trial will be done during the second step where patients with myocardial infarction who are identified with type D personality characteristics, psychological distress, low level of medication adherence, low social support, low quality of life, low acceptance and psychological flexibility will be randomly assigned to two groups i.e. waitlist control group and intervention group. The acceptance and commitment therapy would be implemented on participants in the interventional group. As the control group is the waitlist control group; initially no intervention will be given to participants in the control group but the intervention will be given to the control group participants once the study is completed.

Interventions

OTHERAcceptance and commitment therapy

Introduction: Build rapport and complete pre-assessment questionnaires. First Session: Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework. Second Session: Review feedback and encourage change. Assign homework. Third Session: Discuss acceptance and coping strategies. Assign homework. Fourth Session: Discuss cognitive diffusion and unhelpful thoughts. Assign homework. Fifth Session: Explore self-concept and mindfulness. Assign homework. Sixth Session: Identify and elaborate on values. Assign homework. Seventh Session: Discuss values, goals, and barriers. Assign homework. Eighth Session: Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.

Sponsors

Fatima Jinnah Women University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. First-time diagnosed, non-hospitalized patients with myocardial infarction (MI). 2. Patients attending follow-up visits at the hospital. 3. Patients experiencing distress. 4. Patients exhibiting features of Type D personality. 5. Patients reporting low levels of: * Quality of Life (QoL) * Medication adherence * Social support * Acceptance * Psychological flexibility 6. Patients aged 18 years and above. 7. Both genders. 8. Patients who can understand Urdu. 9. Patients who can provide informed consent.

Exclusion criteria

1. Hospitalized patients with myocardial infarction (MI). 2. Patients with myocardial infarction (MI) and other chronic co-morbid diseases, such as: * Cancer * Cognitive deficits * Chronic psychological disorders 3. Patients with silent myocardial infarction. 4. Patients younger than 18 years.

Design outcomes

Primary

MeasureTime frameDescription
World Health Organization Quality of Life Scale Urdu Version3 monthsIt has 26 items and four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains quality of life and general health items. The minimum value is 26 and the maximum value is 130. Higher scores on the scale indicate higher quality of life and low scores indicate low quality of life.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026